CTKB vs REG · rev $200.5M vs P/E 34, $12.93B cap
Cytek Biosciences Inc (CTKB) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
REG does not have a complete income-statement cache yet.
CTKB currently screens at market cap $421.8M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the CTKB and REG stock pages for the full models.
Not investment advice.